Skip to content
To the full analysis

Kestra Medical Technologies stock: dividend

KMTS
$28.62Closing price of 12 Nov 2026MEQIRI Score 43 out of 100

Kestra Medical Technologies does not currently pay a dividend. Kestra Medical Technologies did not buy back any of its own shares from fiscal 2024 to 2026.

Whether Kestra Medical Technologies, Ltd. pays a dividend and what the company does with its cash instead: free cash flow, buybacks of its own shares and the share count over recent years.

Daily figure as of 13 Nov 2026

Dividend yield over the last 12 months
0%
Dividend per share 2026
$0.01
paid in fiscal 2026
no data
−$2.00
does not cover the dividend of $0.01

Kestra Medical Technologies has paid no dividend in the last 12 months. The payout ratio and coverage therefore refer to the dividend paid in fiscal year 2026, not to a current payment.

The amounts for the last 12 months and paid in fiscal 2026 differ if the company has raised or cut its dividend since then.

Dividend development

Dividend per share

Payout ratio

  • of earnings
  • of free cash flow
Figures as a table
YearDividend per shareEarnings per share
2020$0.0037−$0.59
2021$0.0094−$1.71
2023$0.0135−$1.75
2024$0.0161−$2.04
2025$0.0334−$5.13
2026$0.0055−$2.43

Free cash flow and buybacks

Fiscal yearFree cash flowShare buybacksShares outstanding
2026−$116.6M$058.40M
2025−$101.2M$049.53M
2024−$84.75M$049.53M
2023−$85.1M$049.53M
2021−$30.23M$019.89M
Buyback calculator for Kestra Medical Technologies

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2026, period end 30 Apr 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 6 Mar 2026)
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy